IntelGenx Corp. and RedHill Biopharma Ltd Announce Positive Outcome of the Decentralized Procedure for Approval of RIZAPORT(TM) in Europe
ACCESSWIRE - Thu Sep 10, 8:48AM CDT
The German Federal Institute for Drugs and Medical Devices (BfArM) has confirmed that the European Marketing Authorization Application (MAA) submitted for RIZAPORT(TM) is approvable under the European Decentralized Procedure. IntelGenx and RedHill will submit the final required documentation to the German and Luxembourg regulatory authorities next week, which is expected to lead to marketing approval of RIZAPORT(TM) in both countries and, will continue to collaborate to obtain approvals in other Decentralized Procedure (DCP) European territories. RIZAPORT(TM), an oral thin film formulation of rizatriptan, presents an attractive therapeutic alternative for migraine sufferers. The thin film has a pleasant taste and dissolves rapidly in the mouth without the need for water. Its pocket size packaging makes it ideal for migraine sufferers to carry on the go. Patients can also take their medication without further exacerbating nausea, which is an important factor when selecting a product to treat migraine, according to a survey of US migraine sufferers conducted by the Brand Institute Inc. RedHill and IntelGenx continue to work with the FDA to advance potential approval of the U.S. New Drug Application (NDA) submitted by the companies.
RDHL: 14.47 (+0.62), IGX.VN: 0.680 (-0.020)
RedHill Biopharma and IntelGenx Announce RIZAPORT(TM) (RHB-103) Marketing Authorization Application is Approvable Under the European Decentralized Procedure
GlobeNewswire - Thu Sep 10, 8:00AM CDT
-- The German Federal Institute for Drugs and Medical Devices (BfArM) has confirmed the positive outcome of the European Decentralized Procedure and informed RedHill and IntelGenx that the European Marketing Authorization Application (MAA) for RIZAPORT (RHB-103) is approvable
RDHL: 14.47 (+0.62), IGX.VN: 0.680 (-0.020)
IntelGenx Reports Q2 and First Six Months 2015 Results and Provides Corporate Development Update
ACCESSWIRE - Mon Aug 10, 3:25PM CDT
Revenue up threefold over Q2 and H1 2014; Company achieves $3M milestone payment from Edgemont; Andre Godin, CPA, CA, appointed as Executive Vice-President and CFO; Clemens Mayr, appointed Director; Moving towards positive cash flow by fiscal year-end
IGX.VN: 0.680 (-0.020)
IntelGenx to Provide Second Quarter 2015 Update on August 10, 2015
ACCESSWIRE - Thu Aug 06, 7:14AM CDT
SAINT LAURENT, QB / ACCESSWIRE / August 6, 2015 / IntelGenx Technologies Corp. (TSX VENTURE: IGX) (OTCQX: IGXT) ("IntelGenx"
IGX.VN: 0.680 (-0.020)
IntelGenx Announces Appointment of New Director
ACCESSWIRE - Wed Aug 05, 3:27PM CDT
SAINT LAURENT, QB / ACCESSWIRE / August 5, 2015 / IntelGenx Technologies Corp. (TSXV: IGX) (OTCQX: IGXT) (the "Company" or "IntelGenx"
IGX.VN: 0.680 (-0.020)
IntelGenx Appoints Andre Godin as New Executive Vice-President and Chief Financial Officer
Newsfile Corp - Mon Jul 20, 3:00PM CDT
full story)
IGX.VN: 0.680 (-0.020)
IntelGenx Reports Q1, 2015 Results and Provides Corporate Development Update
ACCESSWIRE - Thu May 14, 3:44PM CDT
SAINT LAURENT, QB / ACCESSWIRE / May 14, 2015 / IntelGenx Technologies Corp. (TSXV: IGX) (OTCQX: IGXT) (the "Company" or "IntelGenx"
IGX.VN: 0.680 (-0.020)
IntelGenx Announces Management Changes
GlobeNewswire - Wed May 13, 4:39PM CDT
IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) ("IntelGenx"
IGX.VN: 0.680 (-0.020)
IntelGenx Confirms Execution of Lease and Construction Agreements
ACCESSWIRE - Tue May 05, 6:49AM CDT
SAINT LAURENT, QB / ACCESSWIRE / May 5, 2015 / IntelGenx Corp. (TSX VENTURE: IGX) (OTCQX: IGXT) ("IntelGenx", or the "Company"
IGX.VN: 0.680 (-0.020)
IntelGenx to Report 2015 First Quarter Update Call on May 15, 2015
GlobeNewswire - Mon May 04, 7:02AM CDT
IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) ("IntelGenx"
IGX.VN: 0.680 (-0.020)
IntelGenx Provides Q1, 2015 Update on Sales of Forfivo XL(R)
GlobeNewswire - Wed Apr 22, 7:15AM CDT
IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) ("IntelGenx", or the "Company"
IGX.VN: 0.680 (-0.020)
IntelGenx Announces Analyst Coverage Initiated by Singular Research
GlobeNewswire - Thu Apr 16, 7:05AM CDT
IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (the "Company" or "IntelGenx"
IGX.VN: 0.680 (-0.020)
IntelGenx Founder, President and CEO Dr. Horst Zerbe Interviewed on Fox Business Network's "After the Bell"
GlobeNewswire - Fri Apr 10, 7:46AM CDT
IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (the "Company" or "IntelGenx"
IGX.VN: 0.680 (-0.020)